Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cathy Eng

Showing results (61-70 of 315) with videos related to

Pageof 32
Sort By:
Clinical Colorectal Cancer|February 7, 2022
Targeted Fibroblast Growth Factor Receptor (FGFR) Inhibition in Recurrent, Metastatic Anal Carcinoma: A Case ReportKayla W Miranda, Sarah K Cimino, Cathy Eng
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 21, 2015
Perspectives on clinical trials for gastrointestinal malignanciesCathy Eng, Nancy Roach, Michele Longabaugh, et al.
Clinical Colorectal Cancer|October 25, 2021
Cutaneous Lymphangitic Carcinomatosis as the First Sign of Recurrent Malignancy in a Patient With a History of Rectal AdenocarcinomaCody Lebeck Lee, Jeffrey Zwerner, Brittany O'Brian, et al.
The Oncologist|December 16, 2023
Mutational Signature Changes in Patients With Metastatic Squamous Cell Carcinoma of the Anal CanalMichael LaPelusa, Christopher Cann, Kristen K Ciombor, et al.
Clinical Colorectal Cancer|December 18, 2013
Atypical metastatic presentations in colorectal cancer: a case seriesJane E Rogers, Aki Ohinata, Arvind Dasari, et al.
Nature Clinical Practice. Gastroenterology & Hepatology|December 3, 2008
Should cisplatin be avoided in the treatment of locally advanced squamous cell carcinoma of the anal canal?Cathy Eng, Christopher H Crane, Miguel A Rodriguez-Bigas
Molecular Carcinogenesis|October 2, 2010
Interactions between cigarette smoking and selected polymorphisms in xenobiotic metabolizing enzymes in risk for colorectal cancer: A case-only analysisMala Pande, Christopher I Amos, Cathy Eng, et al.
Clinical Advances in Hematology & Oncology : H&O|March 15, 2022
Considerations in the management of younger patients With colorectal cancer: Q&AJoleen M Hubbard, Cathy Eng, Chiara Cremolini, et al.
Clinical Colorectal Cancer|April 26, 2006
Southwest Oncology Group 0408: Phase II trial of neoadjuvant capecitabine/oxaliplatin/bevacizumab for resectable colorectal metastases in the liverEddie K Abdalla, Cathy Eng, Alice Madary, et al.
Clinical Advances in Hematology & Oncology : H&O|March 15, 2022
Considerations in the management of younger patients with colorectal cancerJoleen M Hubbard, Cathy Eng, Chiara Cremolini, et al.
Pageof 32

Showing results (61-70 of 315) with videos related to

Sort By:
Pageof 32
Clinical Colorectal Cancer|February 7, 2022
Targeted Fibroblast Growth Factor Receptor (FGFR) Inhibition in Recurrent, Metastatic Anal Carcinoma: A Case ReportKayla W Miranda, Sarah K Cimino, Cathy Eng
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 21, 2015
Perspectives on clinical trials for gastrointestinal malignanciesCathy Eng, Nancy Roach, Michele Longabaugh, et al.
Clinical Colorectal Cancer|October 25, 2021
Cutaneous Lymphangitic Carcinomatosis as the First Sign of Recurrent Malignancy in a Patient With a History of Rectal AdenocarcinomaCody Lebeck Lee, Jeffrey Zwerner, Brittany O'Brian, et al.
The Oncologist|December 16, 2023
Mutational Signature Changes in Patients With Metastatic Squamous Cell Carcinoma of the Anal CanalMichael LaPelusa, Christopher Cann, Kristen K Ciombor, et al.
Clinical Colorectal Cancer|December 18, 2013
Atypical metastatic presentations in colorectal cancer: a case seriesJane E Rogers, Aki Ohinata, Arvind Dasari, et al.
Nature Clinical Practice. Gastroenterology & Hepatology|December 3, 2008
Should cisplatin be avoided in the treatment of locally advanced squamous cell carcinoma of the anal canal?Cathy Eng, Christopher H Crane, Miguel A Rodriguez-Bigas
Molecular Carcinogenesis|October 2, 2010
Interactions between cigarette smoking and selected polymorphisms in xenobiotic metabolizing enzymes in risk for colorectal cancer: A case-only analysisMala Pande, Christopher I Amos, Cathy Eng, et al.
Clinical Advances in Hematology & Oncology : H&O|March 15, 2022
Considerations in the management of younger patients With colorectal cancer: Q&AJoleen M Hubbard, Cathy Eng, Chiara Cremolini, et al.
Clinical Colorectal Cancer|April 26, 2006
Southwest Oncology Group 0408: Phase II trial of neoadjuvant capecitabine/oxaliplatin/bevacizumab for resectable colorectal metastases in the liverEddie K Abdalla, Cathy Eng, Alice Madary, et al.
Clinical Advances in Hematology & Oncology : H&O|March 15, 2022
Considerations in the management of younger patients with colorectal cancerJoleen M Hubbard, Cathy Eng, Chiara Cremolini, et al.
Pageof 32